Blood cancers, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia
Results
Phase 2
This trial looked at low dose lenalidomide and the steroid dexamethasone for people who had already had treatment for chronic lymphocytic leukaemia (CLL).
Recruitment start: 29 November 2012
Recruitment end: 31 December 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Amit C. Nathwani
Celgene
NIHR Clinical Research Network: Cancer
University College London (UCL)
Last reviewed: 19 Mar 2018
CRUK internal database number: 9311
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
